Jon Norman
Impact in
- Virology top 2%
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 14
- vaccines and immunoinformatics approaches 8
- Protein Hydrolysis and Bioactive Peptides 5
- Immunology 11
- Immunotherapy and Immune Responses 9
- Co-authors
- Peter Hobart (12 shared papers)Stephen L. Hoffman (10 shared papers)Suezanne E. Parker (11 shared papers)Richard C. Hedstrom (8 shared papers)Marston Manthorpe (11 shared papers)Yupin Charoenvit (7 shared papers)Denise L. Doolan (6 shared papers)Martha Sedegah (5 shared papers)
- Journals
- Human Gene Therapy (9 papers)Molecular Pharmacology (5 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Vaccine (3 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Jon Norman
54 papers receiving 3.6k citations
Jon Norman's Hit Papers
Peers
Comparison fields: 5 of 120
- Virology 285
- Immunology 1.1k
- Molecular Biology 2.1k
- Infectious Diseases 435
- Genetics 614
Countries citing papers authored by Jon Norman
This map shows the geographic impact of Jon Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Norman more than expected).
Fields of papers citing papers by Jon Norman
This network shows the impact of papers produced by Jon Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Norman. The network helps show where Jon Norman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Norman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine Hit paper breakdown → | 1998 | 648 |
| 2 | 1996 | 279 | |
| 3 | 1996 | 230 | |
| 4 | 1993 | 191 | |
| 5 | 1995 | 179 | |
| 6 | 2001 | 175 | |
| 7 | 2000 | 174 | |
| 8 | 1987 | 157 | |
| 9 | 1999 | 111 | |
| 10 | 1995 | 111 | |
| 11 | 1999 | 104 | |
| 12 | 1979 | 100 | |
| 13 | 1987 | 96 | |
| 14 | 1995 | 93 | |
| 15 | 2001 | 84 | |
| 16 | 1999 | 82 | |
| 17 | 1987 | 80 | |
| 18 | 2004 | 78 | |
| 19 | 1994 | 77 | |
| 20 | 2002 | 69 |
About Jon Norman
Jon Norman is a scholar working on Molecular Biology, Immunology, Cellular and Molecular Neuroscience, Genetics and Public Health, Environmental and Occupational Health, having authored 56 papers that have together received 3.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Immunotherapy and Immune Responses (9 papers), Virus-based gene therapy research (9 papers), vaccines and immunoinformatics approaches (8 papers), Malaria Research and Control (6 papers), Neuropeptides and Animal Physiology (6 papers), Protein Hydrolysis and Bioactive Peptides (5 papers) and Renin-Angiotensin System Studies (4 papers). The work is most often cited by research in Virology (285 citations), Immunology (1.1k citations), Molecular Biology (2.1k citations), Infectious Diseases (435 citations) and Genetics (614 citations). Jon Norman has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Peter Hobart, Stephen L. Hoffman, Suezanne E. Parker, Richard C. Hedstrom, Marston Manthorpe, Yupin Charoenvit, Denise L. Doolan, Martha Sedegah, M Margalith and Ruobing Wang. Their work appears in journals such as Human Gene Therapy, Molecular Pharmacology, Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.